BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34408967)

  • 1. "Growth patterns in children with mucopolysaccharidosis type I-Hurler after hematopoietic stem cell transplantation: Comparison with untreated patients".
    Cattoni A; Chiaraluce S; Gasperini S; Molinari S; Biondi A; Rovelli A; Parini R
    Mol Genet Metab Rep; 2021 Sep; 28():100787. PubMed ID: 34408967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
    Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
    Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.
    Tolar J; Grewal SS; Bjoraker KJ; Whitley CB; Shapiro EG; Charnas L; Orchard PJ
    Bone Marrow Transplant; 2008 Mar; 41(6):531-5. PubMed ID: 18037941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant human growth hormone on changes in height, bone mineral density, and body composition over 1-2 years in children with Hurler or Hunter syndrome.
    Polgreen LE; Thomas W; Orchard PJ; Whitley CB; Miller BS
    Mol Genet Metab; 2014 Feb; 111(2):101-6. PubMed ID: 24368158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucopolysaccharidosis type I.
    Wraith JE; Jones S
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation.
    Polgreen LE; Tolar J; Plog M; Himes JH; Orchard PJ; Whitley CB; Miller BS; Petryk A
    Bone Marrow Transplant; 2008 Jun; 41(12):1005-11. PubMed ID: 18278070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings.
    Yamazaki N; Kosuga M; Kida K; Takei G; Fukuhara Y; Matsumoto H; Senda M; Honda A; Ishiguro A; Koike T; Yabe H; Okuyama T
    Brain Dev; 2019 Jun; 41(6):546-550. PubMed ID: 30755342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Bloodstream Infections after Hematopoietic Stem Cell Transplantation for Hurler Syndrome.
    Dunseath C; O'Connor G; Mahulkar S; Badia P; Koo J; Dandoy CE
    Transplant Cell Ther; 2023 Nov; 29(11):707.e1-707.e4. PubMed ID: 37582469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell transplantation in mucopolysaccharidosis type IIIA: A case description and comparison with a genotype-matched control group.
    Köhn AF; Grigull L; du Moulin M; Kabisch S; Ammer L; Rudolph C; Muschol NM
    Mol Genet Metab Rep; 2020 Jun; 23():100578. PubMed ID: 32226768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstructive sleep apnea and craniofacial appearance in MPS type I-Hurler children after hematopoietic stem cell transplantation.
    Koehne T; Müller-Stöver S; Köhn A; Stumpfe K; Lezius S; Schmid C; Lukacs Z; Kahl-Nieke B; Muschol N
    Sleep Breath; 2019 Dec; 23(4):1315-1321. PubMed ID: 31332621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-L-iduronidase therapy for mucopolysaccharidosis type I.
    Tolar J; Orchard PJ
    Biologics; 2008 Dec; 2(4):743-51. PubMed ID: 19707455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open issues in Mucopolysaccharidosis type I-Hurler.
    Parini R; Deodato F; Di Rocco M; Lanino E; Locatelli F; Messina C; Rovelli A; Scarpa M
    Orphanet J Rare Dis; 2017 Jun; 12(1):112. PubMed ID: 28619065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.
    de Ru MH; Boelens JJ; Das AM; Jones SA; van der Lee JH; Mahlaoui N; Mengel E; Offringa M; O'Meara A; Parini R; Rovelli A; Sykora KW; Valayannopoulos V; Vellodi A; Wynn RF; Wijburg FA
    Orphanet J Rare Dis; 2011 Aug; 6():55. PubMed ID: 21831279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome.
    Eisengart JB; Jarnes J; Ahmed A; Nestrasil I; Ziegler R; Delaney K; Shapiro E; Whitley C
    Mol Genet Metab Rep; 2017 Dec; 13():64-68. PubMed ID: 28983455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of pulmonary function in childhood onset Mucopolysaccharidosis type I.
    Broomfield A; Sims J; Mercer J; Hensman P; Ghosh A; Tylee K; Stepien KM; Oldham A; Prathivadi Bhayankaram N; Wynn R; Wright NB; Jones SA; Wilkinson S
    Mol Genet Metab; 2021 Feb; 132(2):94-99. PubMed ID: 32713717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan.
    Tanaka A; Okuyama T; Suzuki Y; Sakai N; Takakura H; Sawada T; Tanaka T; Otomo T; Ohashi T; Ishige-Wada M; Yabe H; Ohura T; Suzuki N; Kato K; Adachi S; Kobayashi R; Mugishima H; Kato S
    Mol Genet Metab; 2012 Nov; 107(3):513-20. PubMed ID: 23022072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying medical manifestations in Hurler syndrome with the infant physical symptom score: associations with long-term physical and adaptive outcomes.
    Ahmed A; Rudser K; King KE; Eisengart JB; Orchard PJ; Shapiro E; Whitley CB
    Mol Genet Metab; 2022 May; 136(1):22-27. PubMed ID: 35304037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Remodeling in an Mps-1h Girl after Hematopoietic Stem Cell Transplantation along with Enzymatic Replacement Therapy.
    Tummolo A; Brunetti G; Piacente L; Marzollo A; Biffi A; Burlina A; Faienza MF
    Endocr Metab Immune Disord Drug Targets; 2022; 22(14):1425-1432. PubMed ID: 35619307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II.
    Kubaski F; Yabe H; Suzuki Y; Seto T; Hamazaki T; Mason RW; Xie L; Onsten TGH; Leistner-Segal S; Giugliani R; Dũng VC; Ngoc CTB; Yamaguchi S; Montaño AM; Orii KE; Fukao T; Shintaku H; Orii T; Tomatsu S
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1795-1803. PubMed ID: 28673849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome).
    Miebach E; Church H; Cooper A; Mercer J; Tylee K; Wynn RF; Wraith JE
    J Inherit Metab Dis; 2011 Jun; 34(3):755-61. PubMed ID: 21416193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.